Wassil Jim sold $111K of PCVX
Wassil Jim (CHIEF OPERATING OFFICER) sold 2,250 shares of Vaxcyte, Inc. (PCVX) at an average of $49.52 ($49.40–$50.26, $0.11M total) across 2 trades on 2026-06-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A modest insider sell by a senior officer may prompt short‑term caution among traders, but the overall effect is limited given the small dollar amount.
Market read
Primary disclosure of a small insider sale; low trading relevance but provides fresh data for monitoring insider activity.
What to watch
The COO retains a large stake (158,494 shares) indicating continued confidence.
Background
Form 4 filings provide the first public record of insider transactions, offering transparency into insider sentiment.
Ticker impact
SEC Form 4 disclosed COO Wassil Jim sold 2,250 shares for $111,416, a routine insider sale under $1M.
potential slight downward pressure as the market prices in the insider sell.
Insider sales, especially by a senior officer, are often interpreted as a weak signal, but the amount is small relative to holdings.
Market effects
Minimal impact on the biotech sector; the sale is company‑specific.
No broader regional effect.
Not globally relevant.
Counterpoint
The sale could be a routine liquidity event unrelated to fundamentals, so price impact may be negligible.
Key entities
- companyVaxcyte, Inc.
Biotech firm developing vaccine technologies, ticker PCVX.
- personWassil Jim
Chief Operating Officer of Vaxcyte, reported the sale.
